{"id":57814,"date":"2023-07-27T13:04:53","date_gmt":"2023-07-27T11:04:53","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\/"},"modified":"2023-07-27T13:04:53","modified_gmt":"2023-07-27T11:04:53","slug":"marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\/","title":{"rendered":"Marinus Pharmaceuticals to Provide Business Update and Report Second Quarter 2023 Financial Results on August 10, 2023"},"content":{"rendered":"
\n

RADNOR, Pa.–(BUSINESS WIRE)–Marinus Pharmaceuticals<\/a>, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that it plans to release financial results for the second quarter ended June 30, 2023 on August 10, 2023. The Company will host a conference call at 8:30 a.m. Eastern Time on August 10, 2023.<\/p>\n

<\/a>
<\/a><\/p>\n

\nParticipants may access the conference call via webcast on the Investors and Media page of Marinus\u2019 website at ir.marinuspharma.com\/events-and-presentations<\/a>. An archived version of the call will be available approximately two hours after the completion of the event on the website.<\/p>\n

\nAbout Marinus Pharmaceuticals<\/b><\/p>\n

\nMarinus is a commercial stage pharmaceutical company dedicated to the development of innovative therapeutics for seizure disorders. The Company\u2019s commercial product, ZTALMY\u00ae (ganaxolone) oral suspension CV, has been approved by the U.S. FDA for the treatment of seizures associated with CDKL5 deficiency disorder in patients two years of age and older. The potential of ganaxolone is also being studied in other rare seizure disorders, including in Phase 3 trials in tuberous sclerosis complex and refractory status epilepticus. Ganaxolone is a neuroactive steroid GABAA<\/sub> receptor modulator that acts on a well-characterized target in the brain known to have anti-seizure effects. It is being developed in IV and oral formulations to maximize therapeutic reach for adult and pediatric patients in acute and chronic care settings. For more information visit www.marinuspharma.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nCompany<\/b>
Molly Cameron
\n
Director, Corporate Communications & Investor Relations
\n
Marinus Pharmaceuticals, Inc.
\n
mcameron@marinuspharma.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

RADNOR, Pa.–(BUSINESS WIRE)–Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that it plans to release financial results for the second quarter ended June 30, 2023 on August 10, 2023. The Company will host a conference call at 8:30 a.m. Eastern Time on … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-57814","6":"format-standard","7":"category-industry"},"yoast_head":"\nMarinus Pharmaceuticals to Provide Business Update and Report Second Quarter 2023 Financial Results on August 10, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Marinus Pharmaceuticals to Provide Business Update and Report Second Quarter 2023 Financial Results on August 10, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"RADNOR, Pa.–(BUSINESS WIRE)–Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that it plans to release financial results for the second quarter ended June 30, 2023 on August 10, 2023. The Company will host a conference call at 8:30 a.m. Eastern Time on ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-27T11:04:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230727626834\/en\/1638593\/21\/marinus-color.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Marinus Pharmaceuticals to Provide Business Update and Report Second Quarter 2023 Financial Results on August 10, 2023\",\"datePublished\":\"2023-07-27T11:04:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\\\/\"},\"wordCount\":262,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230727626834\\\/en\\\/1638593\\\/21\\\/marinus-color.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\\\/\",\"name\":\"Marinus Pharmaceuticals to Provide Business Update and Report Second Quarter 2023 Financial Results on August 10, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230727626834\\\/en\\\/1638593\\\/21\\\/marinus-color.jpg\",\"datePublished\":\"2023-07-27T11:04:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230727626834\\\/en\\\/1638593\\\/21\\\/marinus-color.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230727626834\\\/en\\\/1638593\\\/21\\\/marinus-color.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Marinus Pharmaceuticals to Provide Business Update and Report Second Quarter 2023 Financial Results on August 10, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Marinus Pharmaceuticals to Provide Business Update and Report Second Quarter 2023 Financial Results on August 10, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\/","og_locale":"en_US","og_type":"article","og_title":"Marinus Pharmaceuticals to Provide Business Update and Report Second Quarter 2023 Financial Results on August 10, 2023 - Pharma Trend","og_description":"RADNOR, Pa.–(BUSINESS WIRE)–Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that it plans to release financial results for the second quarter ended June 30, 2023 on August 10, 2023. The Company will host a conference call at 8:30 a.m. Eastern Time on ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-07-27T11:04:53+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230727626834\/en\/1638593\/21\/marinus-color.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Marinus Pharmaceuticals to Provide Business Update and Report Second Quarter 2023 Financial Results on August 10, 2023","datePublished":"2023-07-27T11:04:53+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\/"},"wordCount":262,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230727626834\/en\/1638593\/21\/marinus-color.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\/","url":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\/","name":"Marinus Pharmaceuticals to Provide Business Update and Report Second Quarter 2023 Financial Results on August 10, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230727626834\/en\/1638593\/21\/marinus-color.jpg","datePublished":"2023-07-27T11:04:53+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230727626834\/en\/1638593\/21\/marinus-color.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230727626834\/en\/1638593\/21\/marinus-color.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-provide-business-update-and-report-second-quarter-2023-financial-results-on-august-10-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Marinus Pharmaceuticals to Provide Business Update and Report Second Quarter 2023 Financial Results on August 10, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/57814","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=57814"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/57814\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=57814"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=57814"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=57814"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}